XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Mezzanine Equity and Shareholders' Equity (Deficit) - USD ($)
Common Stock
Pre-funded warrants
Common Stock
Additional Paid-In Capital
B Riley Sales Agreement [Member]
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Pre-funded warrants
Additional Paid-In Capital
Accumulated Other Comprehensive Income/Loss
Accumulated Deficit
B Riley Sales Agreement [Member]
Public Offering
Pre-funded warrants
Total
Balance at Dec. 31, 2021   $ 2,859       $ 216,442,904 $ 41,942 $ (205,765,107)       $ 10,722,598
Balance (in shares) at Dec. 31, 2021   2,858,244                    
Issuance of common stock to vendors   $ 11       99,990           100,001
Issuance of common stock to vendors (in shares)   11,788                    
Share-based compensation expense           149,941           149,941
Foreign currency translation adjustment             (30,873)         (30,873)
Net loss               (6,735,781)       (6,735,781)
Balance at Jun. 30, 2022   $ 2,870       216,692,835 11,069 (212,500,888)       4,205,886
Balance (in Shares) at Jun. 30, 2022   2,870,032                    
Balance at Mar. 31, 2022   $ 2,864       216,571,171 124,592 (210,114,128)       6,584,499
Balance (in shares) at Mar. 31, 2022   2,863,621                    
Issuance of common stock to vendors   $ 6       49,994           50,000
Issuance of common stock to vendors (in shares)   6,411                    
Share-based compensation expense           71,670           71,670
Foreign currency translation adjustment             (113,523)         (113,523)
Net loss               (2,386,760)       (2,386,760)
Balance at Jun. 30, 2022   $ 2,870       216,692,835 11,069 (212,500,888)       4,205,886
Balance (in Shares) at Jun. 30, 2022   2,870,032                    
Balance at Dec. 31, 2022   $ 2,909       217,064,964 24,747 (219,563,446)       (2,470,826)
Balance (in shares) at Dec. 31, 2022   2,908,578                    
Issuance costs associated with B. Riley At Market Issuance Sales Agreement   $ 851       3,090,611           3,091,462
Issuance of common stock pursuant to B. Riley At Market Issuance Sales Agreement (in shares)   851,130                    
Issuance costs     $ (95,348) $ (834,061)         $ (95,348) $ (834,061)    
Issuance of common stock and pre-funded warrants in connection with May 2023 public offering   $ 2,301       8,493,516           8,495,817
Issuance of common stock and pre-funded warrants in connection with May 2023 public offering (in shares)   2,301,500                    
Issuance of common stock to vendors   $ 50       72,950           73,000
Issuance of common stock to vendors (in shares)   50,000                    
Issuance of common stock upon exercise of pre-funded warrants $ 3,699       $ (400)           $ 3,299  
Issuance of common stock upon exercise of pre-funded warrants (in shares) 3,699,000                      
Issuance of common stock in connection with Silk Roads purchase option   $ 32       49,968           50,000
Issuance of common stock in connection with Silk Roads purchase option (in shares)   31,646                    
Share-based compensation expense           163,676           163,676
Foreign currency translation adjustment             (18,686)         (18,686)
Net loss               (2,658,133)       (2,658,133)
Balance at Jun. 30, 2023   $ 9,842       228,005,876 6,061 (222,221,579)       5,800,200
Balance (in Shares) at Jun. 30, 2023   9,841,854                    
Balance at Mar. 31, 2023   $ 2,930       217,206,966 12,594 (220,609,555)       (3,387,065)
Balance (in shares) at Mar. 31, 2023   2,929,773                    
Issuance costs associated with B. Riley At Market Issuance Sales Agreement   $ 830       3,019,902           3,020,732
Issuance of common stock pursuant to B. Riley At Market Issuance Sales Agreement (in shares)   829,935                    
Issuance costs     $ (93,007) $ (834,061)         $ (93,007) $ (834,061)    
Issuance of common stock and pre-funded warrants in connection with May 2023 public offering   $ 2,301       8,493,516           8,495,817
Issuance of common stock and pre-funded warrants in connection with May 2023 public offering (in shares)   2,301,500                    
Issuance of common stock to vendors   $ 50       72,950           73,000
Issuance of common stock to vendors (in shares)   50,000                    
Issuance of common stock upon exercise of pre-funded warrants $ 3,699       $ (400)           $ 3,299  
Issuance of common stock upon exercise of pre-funded warrants (in shares) 3,699,000                      
Issuance of common stock in connection with Silk Roads purchase option   $ 32       49,968           50,000
Issuance of common stock in connection with Silk Roads purchase option (in shares)   31,646                    
Share-based compensation expense           90,042           90,042
Foreign currency translation adjustment             (6,533)         (6,533)
Net loss               (1,612,024)       (1,612,024)
Balance at Jun. 30, 2023   $ 9,842       $ 228,005,876 $ 6,061 $ (222,221,579)       $ 5,800,200
Balance (in Shares) at Jun. 30, 2023   9,841,854